Title : Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway.

Pub. Date : 2020 Nov

PMID : 33005243






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFbeta1/Smad2/3 pathway. Irbesartan transforming growth factor, beta 1 Rattus norvegicus
2 Changes in the aforementioned indicators were reversed after treatment with irbesartan, where the protein expression levels of TGFbeta1 and p-Smad2/3 in myocardial tissue were also significantly reduced. Irbesartan transforming growth factor, beta 1 Rattus norvegicus
3 Therefore, the present results demonstrated that irbesartan reduced the activity of the TGFbeta1/Smad2/3 pathway and ameliorated diabetic MF by downregulating the expression of TGFbeta1. Irbesartan transforming growth factor, beta 1 Rattus norvegicus
4 Therefore, the present results demonstrated that irbesartan reduced the activity of the TGFbeta1/Smad2/3 pathway and ameliorated diabetic MF by downregulating the expression of TGFbeta1. Irbesartan transforming growth factor, beta 1 Rattus norvegicus